Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,686 INR | -2.08% | -2.42% | -12.37% |
Apr. 29 | Gland Pharma Names COO | MT |
Apr. 29 | Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024 | CI |
Sales 2024 * | 56.49B 677M | Sales 2025 * | 63.2B 758M | Capitalization | 278B 3.33B |
---|---|---|---|---|---|
Net income 2024 * | 8.48B 102M | Net income 2025 * | 11.02B 132M | EV / Sales 2024 * | 4.43 x |
Net cash position 2024 * | 27.5B 330M | Net cash position 2025 * | 31.55B 378M | EV / Sales 2025 * | 3.9 x |
P/E ratio 2024 * |
32.6
x | P/E ratio 2025 * |
25.2
x | Employees | 4,585 |
Yield 2024 * |
0.1% | Yield 2025 * |
0.2% | Free-Float | 38.38% |
Latest transcript on Gland Pharma Limited
1 day | -2.08% | ||
1 week | -2.42% | ||
Current month | -1.45% | ||
1 month | -5.66% | ||
3 months | -15.62% | ||
6 months | +11.65% | ||
Current year | -12.37% |
Managers | Title | Age | Since |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 99-12-31 |
Director of Finance/CFO | - | 19-09-29 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 22-03-09 |
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 99-12-31 |
Yiu Kwan Lau
CHM | Chairman | 69 | 19-06-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1,686 | -2.08% | 254,645 |
24-05-02 | 1,722 | +0.65% | 412,615 |
24-04-30 | 1,711 | -1.04% | 109,691 |
24-04-29 | 1,729 | +0.05% | 219,405 |
24-04-26 | 1,728 | -0.59% | 166,537 |
Delayed Quote NSE India S.E., May 03, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.37% | 3.33B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- GLAND Stock